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Abstract.  We have previously  shown that the perox- 
isomal targeting  signal  in firefly luciferase consists of 
the COOH-terminal  three amino acids of the protein, 
serine-lysine-leucine  (Gould,  S. J.,  G.-A.  Keller,  N. 
Hosken, J. Wilkinson,  and S.  Subramani,  1989. J.  Cell 
Biol.  108:1657-1664).  Antibodies were raised against a 
synthetic peptide that contained this tripeptide  at its 
COOH terminus.  Immunofluorescence  and  immuno- 
cryoelectron microscopy revealed that the anti-peptide 
antibodies  specifically detected peroxisomes in mam- 
malian  cells.  Further characterization  revealed that the 
antibodies  were primarily  directed against the COOH- 
terminal  three amino acids of the peptide.  In Western 
blot experiments,  the antibodies  recognized  15-20 rat 
liver peroxisomal proteins,  but reacted with only a  few 
proteins  from other subcellular compartments.  These 
results provide independent  immunological  evidence 
that the peroxisomal  targeting  signal  identified  in 
firefly luciferase is present in many peroxisomal  pro- 
teins. 
p 
ROTEIN transport into the peroxisome, ER, mitochon- 
drion, or chloroplast requires the translocation of pro- 
teins across one or more biological membranes. The 
transport of proteins into these organelles is mediated by cis- 
acting targeting signals present within the imported proteins. 
Peroxisomal proteins have been shown to contain  either a 
COOH-terminal  peroxisomal  targeting  signal  (PTS) ~ con- 
sisting of a tripeptide of conserved sequence (Gould et al., 
1987, 1988,  1989; Miyazawa et al., 1989), or internal signals 
of undetermined nature (Small et al.,  1987,  1988). There is 
no evidence that covalent modification of peroxisomal pro- 
teins occurs as a  consequence of import  (for a  review of 
peroxisome biogenesis see Lazarow and Fujiki,  1985).  In 
contrast, proteins that are transported into the ER, mitochon- 
drion, or chloroplast generally contain nonconserved, NH2- 
terminal targeting signals of variable length (usually 12-25 
amino acids long) that are cleaved from the protein during 
or after import (for reviews see Walter and Lingappa,  1986; 
Douglas et al.,  1986; Schmidt and Mishkind,  1986; Verner 
and Schatz,  1988). 
We showed earlier that the minimal PTS in firefly lucifer- 
ase is the COOH-terminal  tripeptide serine-lysine-leucine. 
Mutagenesis of the PTS revealed that certain  conservative 
amino acid changes could be made within the signal without 
altering  its ability to act as a PTS.  Specifically, the serine 
Gilbert-Andre Keller's present address is Genenlech, 460 San Bruno Blvd., 
South San Francisco,  CA 94080. 
1. Abbreviations  used in this paper: CAT, chloramphenicol acetyltransfer- 
ase; IriS, peroxisomal  targeting  signal; SCP-2, sterol-carrier-protein-2. 
could be changed to alanine or cysteine and the lysine could 
be changed to arginine or histidine without affecting the ac- 
tivity of the targeting  signal (Gould et al.,  1989). 
This report addresses the question of whether the type of 
PTS identified in firefly luciferase is a common feature of 
peroxisomal proteins. Antibodies were raised to a synthetic 
peptide containing one version of the minimal peroxisomal 
targeting  signal  (serine-lysine-leucine-COOH).  Both  im- 
munofluorescence  and  immunocryoelectron  microscopy 
were used to determine if the antibodies could differentiate 
between proteins of the peroxisomes and those of other cellu- 
lar compartments.  Western blot experiments were also per- 
formed to address the specificity of the antibodies for perox- 
isomal proteins and,  in addition, to determine the diversity 
of peroxisomal proteins recognized by the antibodies. 
Materials and Methods 
Animals 
Male Sprague-Dawley  rats (170-220 g) were used in this study. Standard 
lab chow or standard lab chow supplemented with 0.5 % gemfibrozil (wt/wt) 
was provided  ad libitum for at least 10 d. Animals were fasted overnight 
before being sacrificed. 
Peptides and Production of  Antibodies 
Synthetic peptides (peptide A, NH2-CRYHLKPLQSKL-COOH;  peptide B, 
NH2-CRYHLKPLQ-COOH;  peptide C, NH2-CRYLAGPHGSKL-COOH; 
peptide D, NH2-CRYLAGPHG-COOH)  were obtained from the Agouron 
Institute (La Jolla, CA) both as free peptide and preconjugated  to keyhole 
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corresponded to the COOH-terminus of two peroxisomal proteins from rat, 
acyI-CoA oxidase and the hydratase-dehydrogenase bifunctional enzyme. 
Before injection with the peptide, each rabbit was bled to collect preimmune 
serum. A KLH conjugate of peptide A was injected into each of two rabbits. 
Approximately 8 wk after immunization, sera from the rabbits were tested 
by immunofluorescence  and the serum from the animal with the highest titer 
was used for all subsequent experiments. Serum was used for the immu- 
nofluorescence experiments; for all others an IgG fraction was used. 
Subcellular Fractionations 
Liver homogenates were fractionated as described by Leighton et al. (1968) 
except that preinjection of rats with Triton WR-1339  was omitted and the 
peroxisome-enriched fraction  was  washed only  once.  The  peroxisome- 
enriched  fraction  (which  also  contained  lysosomes, mitochondria,  and 
microsomes) was then further separated by equilibrium density centrifuga- 
tion on a steep linear Metrizamide (20-25 % [wt/wt]) or Nycodenz (10-60 % 
lwt/wt]) gradient (Bronfman et al.,  1979;  Hajra and Bishop, 1982).  This 
peroxisome isolation procedure was improved by the incorporation of a re- 
verse sucrose gradient in the Nycodenz or Metrizamide gradients. Spe- 
cifically, a 5 % final concentration of sucrose was added to the 10% (wt/vol) 
Nycodenz solution or a  3.3%  final  concentration of sucrose to  a  20% 
(wt/vol) Metrizamide solution at the time of gradient formation. Addition 
of sucrose creates an essentially iso-osmolar environment throughout the 
gradient. This technique results in the isolation of peroxisomes that more 
closely resemble their in situ appearance (as determined by electron micros- 
copy) and also substantially increases the yield of intact peroxisomes. The 
gradient  was  centrifuged  (model  OTD  75B;  Sorvall  Instruments  Div., 
Newton, CT)  using an ultra-vertical TV 850 rotor at 40,000  rpm for 50 
min at 8°C. A total of 20-25 fractions were collected from the bottom of 
the centrifuge tube with a two-way needle. The mitochondrial and perox- 
isomal fractions of  greatest purity (95-98%) were used for immunoblotting. 
Rat liver microsomes were prepared by differential centrifugation (de Duve 
et al., 1955),  resulting in a microsomal and soluble fraction. All cell frac- 
tions were assayed for protein content and distribution of marker enzymes. 
Isolation of  Membranes 
Purified peroxisomal fractions (95-98 % pure) prepared by equilibrium den- 
sity centrifugation were treated with  sodium carbonate as described by 
Fujiki et al. (1982). The membranes isolated by this technique retain integral 
membrane proteins and exhibit a  normal trilaminar appearance. 
Assay of  Marker Enzymes 
The activities of catalase (a peroxisomal marker) and cytochrome oxidase 
(a mitochondrial marker) were measured according to Leighton et al. (1968) 
and Lazarow and de Duve (1973).  Esterase (a microsomal marker) was 
measured according to Beaufay et al. (1974). Protein was determined by the 
method of Lowry et al. (1951) using BSA as a standard. Since Metrizamide 
interferes with the determination of protein, aliquots of the gradient samples 
were first precipitated in  10%  TCA. 
SDS Gel Electrophoresis and Immunoblotting 
Proteins were separated on 9% or 10% polyacrylamid  e slab gels containing 
0.1%  SDS, by the method of Laemmli (1970).  Electrophoresis was per- 
formed as 35  mA/gel.  Protein samples were prepared in solubilization 
buffer (0.0625 M Tris/HCI, pH 6.8, 2 % SDS, 5 % beta-mercaptoethanol, 5 % 
glycerol, and 0.005%  bromophenol blue) and boiled for 2 min before load- 
ing onto the gel. The separated proteins were electrophoretically transferred 
to nitrocellulose paper in 20 mM Tris, 150 mM glycine and 20% methanol. 
The nitrocellulose was incubated for 2 min in PBS with 2% Tween-20, fol- 
lowed by incubation for 2 h at room temperature with an lgG fraction of 
the anti-peptide antibodies. After several washes, the nitrocellulose was in- 
cubated with horseradish peroxidase-conjugated goat anti-rabbit IgG for 60 
min. 
Immunofluorescence Microscopy 
CV-I cells plated on coverslips were fixed with 3% formaldehyde in PBS 
(pH 7.2) for 15 min. They were then permeabilized with 1% Triton X-100 
for 5 min, after which they were washed extensively with PBS. The rabbit 
anti-peptide serum was applied at a dilution of 1:200. The cells were washed 
extensively again  and  incubated with  a  rhodamine-conjugate of a  goat 
anti-rabbit IgG antibody. The cells were washed with PBS and mounted as 
described (Keller et al., 1987).  In the peptide competition experiments, the 
peptides were preincubated with the antibody for 10 min before application 
to the cells. 
The  plasmid  pSV2CAT-PMP20  was  used  to  demonstrate  that  the 
anti-SKL antibody recognized peroxisomes in immunofluorescence  experi- 
ments. This plasmid contains the last  12 amino acids of the  C.  boidinii 
peroxisome membrane-associated protein, PMP20 (Garrard et al.,  1989), 
fused to the COOH terminus of chloramphenicol acetyltransferase (CAT), 
a cytosolic protein. The fusion protein (CAT-PMP20), when expressed in 
CV1 cells from the SV-40 early promoter in pSV2CAT-PMP20,  is targeted 
to peroxisomes as judged by its co-localization with catalase in double in- 
direct immunofluorescence experiments (Gould, S. J., G. -A. Keller, M. 
Schneider, S. H. Howell, L. J. Garrard, J. M. Goodman, B. Distel, H. Ta- 
bak,  and S.  Subramani,  manuscript submitted for publication).  For the 
double-labeling experiments described in this paper, the plasmid pSV2CAT- 
PMP20 was transfected into CV-1 cells and the cells were fixed 2 d after 
transfection. Double indirect-immunofluorescence was carried out essen- 
tially as described (Gould et al., manuscript submitted for publication) ex- 
cept that the rabbit antibody was the anti-PTS antibody (at a 1:200 dilution), 
not an anti-catalase antibody. Fluorescence microscopy was performed on 
a Zeiss photoscope II microscope. 
lmmunocryoelectron Microscopy 
Small blocks of liver from rats were chopped in 3%  formaldehyde, 0.5% 
glutamldehyde in 0.1  M  phosphate buffer (pH 7.4),  and immersed in the 
same fixative for i  h. After washing in 0.1  M phosphate buffer (pH 7.2), 
the blocks were infused with 2.3 M sucrose for 30 rain. UItrathin sections 
were obtained by cryoultmmicrotomy, as described by Tokuyasu (1980). Im- 
munolabeling was performed essentially as described (Keller et al., 1986) 
except that the primary antibody was the anti-PTS antibody (1:200 dilution 
of the IgG fraction). After washing, the sections were treated with colloidal 
gold (6-8 nm in diameter) adducts of guinea pig antibodies to rabbit IgG. 
Immunolabeled frozen sections were osmicated and poststained with  1% 
aqueous uranyl acetate, dehydrated in a series of ethanol solutions to 95 % 
ethanol, and infused in LR white acrylic resin (Polysciences Inc., Warring- 
ton, PA). 
Results 
Characterization of  Anti-Peptide Antibodies that 
Recognize the Minimal Peroxisomal Targeting Signal 
Rabbits were injected with a  12-amino acid-long peptide 
(peptide A, NH2-CRYHLKPLQSKL-COOH)  ending at the 
COOH  terminus  in  the  amino acids  serine-lysine-leucine 
(the minimal PTS).  Antibodies obtained from immunized 
rabbits were then used in immunofluorescence experiments 
with CV-1 monkey kidney cells. As expected, incubation of 
CV-1 cells with preimmune serum resulted in nonspecific 
staining of the cell (Fig. 1 a). In contrast, the immune serum 
labeled punctate structures within the cells, the morphology 
and distribution of which are characteristic of peroxisomes 
(Fig. 1 b). To confirm that these vesicles were indeed peroxi- 
somes, double-labeling experiments were performed. CV-1 
cells expressing the fusion protein CAT-PMP20,  a  known 
peroxisomal protein (Gould, S. J., G.-A. Keller, M. Schnei- 
der, S. H. Howell, L. J. Garrard, J. M. Goodman, B. Distel, 
H. Tabak, and S. Subramani, manuscript submitted for pub- 
lication), were processed for immunofluorescence micros- 
copy using both the anti-peptide serum (rabbit) and an anti- 
CAT monoclonal  antibody (mouse) that reacts with the CAT- 
PMP20 fusion protein. The subcellular distribution of pro- 
teins recognized by the anti-peptide serum was superimpos- 
able with the distribution of the peroxisomal CAT-PMP20 
protein (Fig.  1, c and d). This result demonstrates that the 
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ognizes  the  tripeptide  SKL  and  labels 
peroxisomes  in  indirect  immunofluores- 
cence experiments.  CV-I monkey kidney 
cells were used  for indirect  immunofluo- 
rescence using the following primary anti- 
bodies.  (a)  Preimmune  rabbit  antibody; 
(b,  c,  and  e-h)  rabbit  anti-peptide  anti- 
body; and (d) mouse monoclonal against 
the CAT-PMP20 fusion protein  which is 
peroxisomal  (Gould, S. J., G.-A.  Keller, 
M. Schneider,  S.  H.  Howell,  L. J.  Gar- 
rard, J. M. Goodman, B. Distel, H. Tabak, 
and S. Subramani,  manuscript submitted 
for  publication).  Secondary  antibodies 
were  rhodmaine-conjugated  goat  anti- 
rabbit antibody for all sections except for 
d, where fluorescein-conjugated  goat an- 
ti-mouse IgG was used. Only the immune 
serum shows the punctate labeling pattern 
(compare a  with b),  which co-localizes 
with  the distribution  of a  known perox- 
isomal protein (c and d). Competition ex- 
periments  show that the anti-peptide anti- 
body is directed  against the minimal  PTS 
(Ser-Lys-Leu-COOH). The primary anti- 
peptide  antibody was competed with the 
following  peptides  before  its  use  for in- 
direct immunofluorescence.  (e) Peptide A 
(CRYHLKPLQSKL), 2 ~g/ml; (f) pep- 
tide C (CRYLAGPHGSKL), 2/zg/ml; (g) 
peptide B (CRYHLKPLQ), 200 ttg/ml; (h) 
peptide  D  (CRYLAGPHG), 200 #g/ml. 
Competition for peroxisomal labeling  (e 
and f) is seen only with peptides A and C 
which end in the tripeptide  SKL, but not 
with peptides B and D which lack this PTS 
(g and h). 
Gould et al. Antibodies against the Peroxisomal Targeting Signal  29 Figure 2. The anti-PTS antibodies recognize peroxisomes by immunocryoelectron microscopy. Rat liver sections were prepared  for im- 
munocryoelectron microscopy as described in Materials and Methods. Electron-dense gold particles represent the distribution of proteins 
in the cell recognized by the anti-PTS  antibodies. The gold particles specifically decorate the peroxisomes of the cell and do not label 
other organelles such as the smooth ER (A), the mitochondria  (B and C), or the Golgi apparatus  (C). 
vesicular structures recognized by the antiserum are peroxi- 
somes. 
Synthetic peptides were used in competition experiments 
to determine which amino acids of the peptide the anti-se- 
rum was directed against.  Four different synthetic peptides 
were used as competitors: peptide A,  the peptide used for 
immunization  (NH2-CRYHLKPLQSKL-COOH);  peptide 
B,  identical to peptide A  except that it did not contain the 
COOH-terminal  three  amino  acids  (NH2-CRYHLKPLQ- 
COOH); peptide C, which, like peptide A, ended in serine- 
lysine-leucine (NH2-CRYLAGPHGSKL-COOH); and pep- 
tide D,  identical to peptide C  except that it did not contain 
the  COOH-terminal  serine-lysine-leucine (NH2-CRYLAG- 
PHG-COOH). The anti-peptide serum was incubated sepa- 
rately with each peptide before use for immunofluorescent 
staining of CV-1 cells.  Preincubation with peptides A  or C 
at a concentration of 2 gg/ml completely abolished the abil- 
ity of the serum to label peroxisomes (Fig.  1, e and  f). How- 
ever,  incubation of the  serum with peptides B or D  at the 
same concentration  (2  gg/ml), or even at  100-fold greater 
concentration (200 ~tg/ml),  did not affect its ability to label 
peroxisomes (Fig.  1, g and h). The presence of the COOH- 
terminal  tripeptide  serine-lysine-leucine in peptides which 
did compete for antibody binding (A and C),  was the only 
difference between them and peptides B and D, which did 
not. Thus, detection of peroxisomal proteins by the immune 
serum  was  mediated  by  its  recognition  of  the  sequence 
serine-lysine-leucine-COOH, the minimal PTS. 
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the anti-PTS antibodies. P, peroxisomes; ER, endoplasmic reticu- 
lum (microsomes); M, mitochondria; C, cytosol; N, nuclei. Num- 
bers at the top of the gel refer to the micrograms of protein loaded 
in the lane below the numbers. The numbers and arrows at the left 
edge of the figure represent molecular mass markers (in kilodal- 
tons).  Note that the anti-PTS  antibodies recognize many perox- 
isomal proteins but only a few proteins in other subcellular frac- 
tions. 
P  [1/~g]). Nevertheless, the serum did react weakly with a 
few proteins unique to ER, mitochondrial, cytosolic, or nu- 
clear fractions that could not be explained by peroxisomal 
contamination. 
The reactivity of the anti-PTS antibody towards perox- 
isomal  membrane  proteins  was  determined  by additional 
Western  blot  experiments.  Purified peroxisomes from rat 
livers were subjected to high pH (11.5)  sodium carbonate 
treatment to strip all nonintegral proteins from the peroxi- 
some membrane (Fujiki  et al.,  1982).  Soluble and  mem- 
brane fractions of peroxisomes were then used in Western 
blot experiments. The three lanes on the left side of Fig. 4 
are Western blot profiles of whole (W),  soluble  (S),  and 
membrane (M) proteins from purified peroxisomes. We used 
50/~g of whole peroxisomal proteins, 45/~g of soluble pro- 
teins, and 5 ~g of membrane proteins in this experiment to 
mimic the  approximate content of soluble and  membrane 
proteins in the peroxisomes. The protein composition of the 
membrane fraction (as determined by analysis of Coomas- 
sie-stained protein gels)  closely matched that of previous 
reports (Fujiki et al., 1982) and, as expected, differed signifi- 
cantly from that of the soluble fraction. It is apparent that 
most proteins recognized by the antibodies were from the 
soluble fraction. The antibodies recognized several proteins 
Anti-PTS Antibodies Recognize Peroxisomes by 
Electron Microscopy 
Immunocryoelectron microscopy experiments provided ad- 
ditional confirmation that the anti-PTS antibodies specifi- 
cally detected peroxisomal proteins.  Portions of rat livers 
were frozen, sectioned, and incubated with anti-PTS anti- 
bodies. Secondary antibodies (conjugated with gold parti- 
cles) were used to visualize the subcellular distribution of 
proteins recognized by the antibodies. As evidenced by the 
distribution of electron-dense gold particles, the antibodies 
labeled the peroxisomes of the cells (Fig. 2). The specificity 
of this antibody for peroxisomal proteins was demonstrated 
by the fact that neither the ER nor other organelles were la- 
beled above background levels (Fig. 2). Significantly, the an- 
tibody recognized proteins in the peroxisome matrix but no 
labeling of the peroxisome membranes was observed. 
Anti-PTS Antibodies Recognize Multiple 
Peroxisomal Proteins 
The specificity of the anti-PTS antibodies was also tested in 
Western blot experiments. Purified peroxisomal, ER (micro- 
somal), mitochondrial, cytosolic, and nuclear proteins from 
rat liver cells were separated by SDS-PAGE, transferred to 
nitrocellulose filters, and probed with the anti-PTS antibody. 
The antibodies recognized at least 16 proteins present in the 
purified peroxisomal fraction (Fig. 3; P, 50/~g) but reacted 
with only a small number of proteins present in the ER (ER, 
50 t~g), mitochondrion (M, 50/~g), cytosol (C,  50/~g), or 
nucleus (N, 50 #g). The two bands present in all lanes (mo- 
lecular masses of '~80 and 26 kD, respectively) were due to 
unavoidable contamination of nonperoxisomal fractions with 
peroxisomes ('~1-4% contamination; compare the lanes of 
ER [50/zg], M [50/xg], C [50 ftg], and N [50 #tg] with lane 
Figure 4. Western blot of whole (W), soluble (S), and membrane 
(M) fractions of rat liver peroxisomes using the anti-PTS antibod- 
ies. Peroxisomes were obtained from either normal rats (left three 
lanes) or from rats fed a diet containing the hypolipidemic drug 
Gemfibrozil (right three lanes).  Numbers at the top refer to the 
amount of protein loaded in each lane (in micrograms). The num- 
bers and arrows at the left edge of the figure represent molecular 
mass markers (in kilodaltons). 
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1984). Concomitant with this increase in peroxisome num- 
ber there is an increase in the amount of peroxisomal pro- 
teins within the cell and a change in the relative abundance 
of several peroxisomal proteins. Comparison of total rat liver 
proteins detected by the antibodies from normal (Fig. 4, lane 
W on left) and drug-fed (lane W on right) rats revealed that 
the  antibodies  recognized additional  proteins  in  drug-fed 
rats.  This result is consistent with previous reports on the 
peroxisome-inducing effects of hypolipidemic drugs  (Lal- 
wani et al.,  1983). Though proteins comprising the mem- 
brane and soluble fractions were quite different on Coomas- 
sie-stained gels, the patterns of bands on the Western blots 
in each fraction were again almost identical. 
We also tested whether the anti-PTS antibodies could de- 
tect  known  peroxisomal proteins,  in  this  case  luciferase, 
sterol-carrier-protein-2 (SCP-2) or catalase. Luciferase con- 
tains the tripeptide PTS serine-lysine-leucine at its COOH 
terminus, and SCP-2, recently shown to be peroxisomal in 
rat liver cells (Keller et al., 1989), ends in a form of the PTS, 
alanine-lysine-leucine  (Morris  et  al.,  1988).  However, 
purified  catalase  lacks  its  COOH-terminal  20-30  amino 
acids due to proteolysis (Furuta et al.,  1986) and its PTS 
(possibly the tripeptide serine-histidine-leucine at positions 
516-518 of the 526 amino acid protein) is contained within 
that region of the protein (Gould et al.,  1988). Both lucifer- 
ase and SCP-2 contain the tripeptide PTS and were detected 
by the anti-PTS antibodies (Fig.  5,  lanes 2  and 3,  respec- 
tively) whereas catalase, the protein lacking the consensus 
PTS sequence, was  not (Fig.  5, lane/). 
Figure 5. The anti-PTS antibody recognizes other pure peroxisomal 
proteins known to contain the PTS. Western blot of purified cata- 
lase, SCP-2, and luciferase using the anti-PTS antibody. The anti- 
body (which was made against the COOH-terminal peptide se- 
quence of a different peroxisomal protein, acyi CoA oxidase) does 
not detect catalase (lane 1 ), but does detect SCP-2 (lane 2, 13.5  kD, 
see arrow), and luciferase (lane 3, 60 kD). The arrows and numbers 
at the left edge of the figure represent molecular mass markers (in 
kilodaltons). 
in the membrane fraction, but most appeared to be residual 
soluble proteins  remaining  in  the  membrane preparation. 
This was surprising considering that the overall protein com- 
position of the soluble and membrane fractions were dramat- 
ically different on Coomassie-stained gels. The fact that only 
trace amounts of soluble peroxisomal proteins are sufficient 
to give a strong signal on Western blots of peroxisomal mem- 
brane fractions indicates that the affinity of the antibodies for 
these proteins is quite high. Some unique bands were present 
in the membrane fraction, but none corresponded to any pre- 
viously  identified peroxisomal  membrane  proteins.  Also, 
some of these bands were not visible in blots of total perox- 
isomal proteins, indicating that they may have been degrada- 
tion products.  These results extend those obtained by im- 
munocryoelectron microscopy and indicate that the anti-PTS 
antibodies recognize many soluble peroxisomal proteins, but 
few, if any,  peroxisomal membrane proteins. 
We  repeated  these  experiments  with  liver peroxisomes 
from rats  that had been fed the hypolipidemic drug gem- 
fibrozil. This drug causes a marked increase in the number 
Discussion 
We previously identified the minimal PTS in firefly luciferase 
and showed that it consists of the COOH-terminal tripeptide 
serine-lysine-leucine (Gould  et  al.,  1989).  An  important 
question raised by this earlier observation was whether other 
peroxisomal proteins also contained a similar type of target- 
ing signal. The type of PTS identified in luciferase is present 
in several of the peroxisomal proteins for which sequences 
are available (Gould et al.,  1988,  1989). Data in this paper 
provide independent immunological evidence that the PTS is 
indeed conserved in many mammalian peroxisomal proteins. 
Immunofluorescence  and  immunocryoelectron  micros- 
copy experiments demonstrated that immune serum raised 
against  a  peptide ending  in  the  PTS specifically detected 
peroxisomes, presumably because it was directed against the 
PTS and thus recognized many peroxisomal proteins. Two 
sets of experiments demonstrated that the antibodies were 
directed against the COOH-terminal three amino acids of the 
peptide. First, two different peptides containing the COOH- 
terminal PTS sequence competed efficiently for labeling of 
peroxisomes by anti-serum (in immunofluorescence experi- 
ments) whereas the same peptides lacking serine-lysine-leu- 
cine at their COOH termini were unable to compete. Second, 
Western blots of purified peroxisomal proteins (luciferase, 
SCP-2, catalase) revealed that the antibodies only recognized 
proteins that  contained the  PTS  sequence  (luciferase and 
SCP-2). It should be noted that the peptide used as antigen 
contained the same COOH-terminal nine amino acids as rat 
acyl-CoA oxidase. The ability of the anti-peptide antibody 
to recognize firefly luciferase and rat SCP-2, as well as many 
unidentified peroxisomal proteins, supports our conclusion 
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common to each protein. 
The specificity of the antibodies for the sequence serine- 
lysine-leucine-COOH was not altogether unexpected. Before 
injection into rabbits,  the antigenic  peptide (NH2-CRYHLK- 
PLQSKL-COOH) was coupled via its NH2-terminal cysteine 
residue to the carrier protein keyhole limpet hemocyanin. 
Thus, the COOH-terminal portion of the peptide should have 
been more exposed and accessible than the NH2-terminal 
portion of the peptide. As a result, it was expected that result- 
ing antibodies would more likely be  directed against the 
COOH terminus of the peptide. 
Western blots of purified peroxisomal proteins  (probed 
with the antibodies) revealed that at least 16 different perox- 
isomal proteins could be detected by the antibodies. In con- 
trast, only a few proteins were detected by the antibodies in 
the ER, mitochondrial, cytosolic, or nuclear fractions and 
the signal observed in these cases was quite weak. Assuming 
that the proteins detected on the Western blots were suffi- 
ciently abundant to be visible on the Coomassie-stained gel 
of peroxisomal proteins (all but a few of the reactive bands 
did correspond to a  band on the Coomassie-stained gel), 
~44% of the 39 peroxisomal proteins on the gels were rec- 
ognized by the antibody. The large number of peroxisomal 
proteins detected by the anti-PTS antibodies demonstrates 
that the type of PTS identified in luciferase is a feature of 
many peroxisomal proteins. 
There  are  several  plausible  explanations  for  why  the 
anti-PTS antibodies failed to detect all peroxisomal proteins. 
Two possibilities for which examples already exist are (a) 
that some proteins may undergo proteolysis, lose the tripep- 
tide PTS,  and no longer be detected by the antibodies, and 
(b) that certain peroxisomal proteins may contain a different 
type of PTS not related to the tripeptide PTS of luciferase. 
It has been reported that purified catalase commonly lacks 
its COOH-termina120 amino acids (Furuta et al., 1986). Be- 
cause  peroxisomal  targeting  activity  has  been  identified 
within the COOH-terminal 27 amino acids of this protein 
(Gould et al., 1988), it is likely that mature catalase has lost 
its PTS. As for the second possibility, Small et al. (1988) have 
identified two regions of the yeast (Candida tropicalis) acyl- 
CoA oxidase that bear no relation to the PTS identified in lu- 
ciferase yet appear to act as peroxisomal targeting signals. 
Another important possibility is that the anti-PTS antibod- 
ies used in this report may, in fact, recognize only a subset 
of the forms of the tripeptide PTS. As mentioned earlier, we 
have demonstrated that several conservative amino acid sub- 
stitutions within the PTS  of luciferase had no discernible 
effect on peroxisomal targeting (serine changed to alanine or 
cysteine; lysine changed to arginine or histidine; Gould et 
al., 1989).  The anti-PTS antibodies described in this paper 
were raised against a peptide that contained only one of the 
nine possible permutations of  the PTS, serine-lysine-leucine. 
It is possible that antibodies directed against different forms 
of the tripeptide PTS would recognize a different subset of 
peroxisomal proteins. We are currently attempting to raise 
antibodies that recognize each of the nine known permuta- 
tions of the tripeptide PTS. 
Additional experiments revealed that the anti-PTS anti- 
body detected soluble peroxisomal proteins very well but 
recognized peroxisomal membrane proteins poorly, if at all. 
Though a few bands were observed only on blots of perox- 
isomal membrane proteins, none corresponded to any mem- 
brane proteins visible on the Coomassie-stained gel. In con- 
trast,  most  soluble peroxisomal  proteins  detected by  the 
antibodies  corresponded  to  proteins  on  the  Coomassie- 
stained gels. Furthermore, the immunoelectron microscopy 
experiments with the anti-PTS antibody revealed labeling of 
the peroxisome matrix and not of the membrane. These ob- 
servations raise the interesting possibility that peroxisomal 
membrane proteins may use a different type of PTS from that 
of soluble peroxisomal proteins. If true, the use of different 
targeting signals by membrane and soluble peroxisomal pro- 
teins might explain certain results obtained in the study of 
cells from human patients with Zellweger's Syndrome, a 
genetic  disorder  resulting  in  peroxisomal  abnormalities. 
Specifically, cells from these patients appear to be incapable 
of importing peroxisomal matrix proteins into the organelle, 
but are still able to assemble certain peroxisomal membrane 
proteins into peroxisome-like "ghosts" (Suzuki et al.,  1987; 
Santos et al., 1988a,b). Since sequences are not yet available 
for mammalian peroxisomal membrane proteins, we do not 
know whether they contain SKL or some other peroxisomal 
membrane targeting signal. 
The anti-PTS antibodies we have raised should be useful 
for a number of purposes.  We have described their application 
as a general probe for detection of many peroxisomal pro- 
teins. Thus, they should be of use as general markers for 
peroxisomes and peroxisomal proteins. Preliminary experi- 
ments already show that they do indeed recognize peroxi- 
somes from diverse species.  The antibodies may also be 
capable of identifying clones encoding peroxisomal proteins 
in cDNA expression libraries and be applicable as a diagnos- 
tic tool for detecting disorders that affect peroxisomal pro- 
teins, such as ZeUweger's  syndrome. Perhaps the most in- 
teresting possibility is the potential use of the antibodies as 
antigens for production of anti-idiotypic antibodies. Anti- 
idiotypic antibodies raised against anti-PTS antibodies may 
be capable of detecting the putative receptor for the PTS. A 
similar strategy using anti-idiotypic antibodies has already 
been exploited by Pain et al. (1988) to identify a receptor for 
the chloroplast targeting signal. Considering that no infor- 
mation is available regarding the components of the perox- 
isomal translocation machinery, identification of a receptor 
for the PTS would be an important step towards elucidation 
of the mechanism of protein transport into the peroxisome. 
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Note Added in Proof'. The recognition of all except for two of the perox- 
isomal proteins by the anti-PTS antibody in Western blots was abolished 
by preincubation of the antibody with a peptide ending in the sequence SKL 
(peptide A) but not by a  peptide lacking the SKL sequence (peptide B), 
demonstrating that the antibody does indeed recognize the PTS in many 
peroxisomal proteins. 
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